Life Science Investing BioVaxys Strengthens Scientific Team with Addition of Former IMV Vice President of R&D
Life Science Investing BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission Process
Life Science Investing BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement
Nine Mile Metals Announces Certified High-Grade Assay Results up to 15.21% Copper from the Wedge Project, Bathurst, New Brunswick
